Webinars

OUR WEBINARS



November 3rd , 2021

PRObiotics in Derm: PROficient or Not?

John Kraft

MD, FRCPC


Charles W. Lynde

MD, FRCPC,DABD, FCDA


Please join us on Wed, Nov 3rd, 2021 7:00 PM - 8:00 PM EDT for our next important webinar
Review the relationship between the gut microbiome and atopic dermatitis pathogenesis Review the data on probiotics and their therapeutic value in treating children with atopic dermatitis


November 1st , 2021

CeraVe SkinChat: The Development of Newborn and Infant Skin – A European-Based Consensus on the Role of Skincare and Ceramides

Giuseppe Micali

MD


Lawrence Schachner

MD, FAAD, FAAP


Please join us on Mon, Nov 1st, 2021 12:00 PM - 1:00 PM EDT for our next important webinar
The skin of neonates and infants is still developing anatomically and functionally, and, therefore, is more susceptible to skin barrier disruption. Increasingly, evidence supports skincare starting early in life, recognizing the benefits of ongoing daily use of non-alkaline cleansers and moisturizers to maintain skin barrier function. When applied from birth onwards, gentle cleansers and moisturizers containing barrier lipids help maintain the protective skin barrier and soothe the skin with long-term moisturizing benefits.
In this webinar we will explores challenges in caring for neonates and infants' skin and the implications for skincare recommendations.


October 26th , 2021

Introducing a new topical treatment for plaque psoriasis and Working together for the benefit of patients: a view from the CEO

Please join us on Tue , Oct 26th, 2021 7:00 PM - 8:00 PM EDT for our next important webinar
Join us for our next IDEF Educational session where Dr. Pearl Kwong will introduce a new topical treatment for plaque psoriasis. Then we will hear from the CEO of EPI Health, John Donofrio for his session, working together for the benefit of patients: a view from the CEO of EPI Health.


October 6th , 2021

Strategies to Treat Acne and Avoid Antibiotic Resistance

Charles Lynde

MD, FRCPC, DABD, FCDA


Lyn Guenther

MD, FRCPC


Please join us on Wed, Oct 6th, 2021 7:00 PM - 8:00 PM EDT for our next important webinar
In this one hour educational session, join us as Dr. Lynde and Dr. Guenther discuss strategies to treat acne and avoid antibiotic resistance


September 28th , 2021

Why does patient quality of life matter in acne?

Leon Kircik

MD, FAAD


Ted Lain

MD, MBA, FAAD


Please join us on Tue, Sep 28, 2021 7:00 PM - 8:00 PM EDT for our next important webinar
Acne is one of the most common dermatological disorder that often occurs in puberty and young adulthood, times of great psychological vulnerability. In fact, acne can be considered as a triple threat in dermatology: medical, aesthetic, and psychological. In this webinar, we will review results from a recent patient global survey that highlights acne patient perceptions regarding their acne. In addition, we will discuss strategies on managing these perceptions increasing treatment compliance, safety and effectiveness.


September 27th , 2021

An Algorithm for Patients With Oncology Treatment-Related Skin Toxicities

Dr. Maxwell Sauder

MD, FRCPC, DABD


Dr. Charles Lynde

MD, FRCPC, DABD, FCDA


Please join us on Mon, Sep 27, 2021 7:00 PM - 8:00 PM EDT for our next important webinar
Cancer treatment has significantly improved overall survival and progression-free survival of patients; however, adverse cutaneous reactions are common. If not treated effectively, cutaneous sequelae may lead to severe morbidities that seriously affect the patients' quality of life (QoL) and decrease cancer-treatment outcomes. Join us as Doctor Charles Lynde, MD, FRCPC, DABD, FCDA and Doctor Maxwell Sauder, MD, FRCPC, DABD, FCDA discuss the CaSMO algorithm, focused on general skincare measures that may help prevent or reduce the severity of cancer- treatment-related skin toxicities, improving treatment tolerability leading to improved patient outcomes.


September 21th , 2021

Over-the-Counter Products for Acne Treatment and Maintenance in Latin America: A Review of Current Clinical Practice

Carmen Gloria Gonzalez

MD


Olga Macias

MD


Please join us on Tue, Sep 121, 2021 7:00 PM - 8:00 PM EDT for our next important webinar
This review aims at insight into the role of over-the-counter (OTC) products in acne treatment and maintenance in Latin America. An expert panel of Latin American dermatologists agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, are a crucial part of successful acne therapy. It was also noted that the use of quality OTC products could improve acne symptomatology and severity.


September 14th , 2021

Over-the-Counter Products as Adjunctive Acne Care in Asian Phototypes: Improving Outcomes and Managing Side Effects

Xian Jiang,

MD, Ph


Kanokvalai Kulthanan

MD


Please join us on Tue, Sep 14th, 2021 7:00 AM - 8:30 AM EDT for our next important webinar
In this webinar, Xian Jiang, MD, PhD and Kanokvalai Kulthanan, MD will explore the differences in acne in Asian phototypes when comparing different ethnicities. They will discuss the challenges in treating acne and review therapeutic options, the role of moisturizers, cleansers and their key ingredient in treating acne and restoring skin barrier function in Asian Skin.


August 10th 2021

NOT ANOTHER BIOLOGIC TALK: DISCOVER INNOVATIONS OF TOPICAL TREATMENT FOR PSORIASIS

Leon Kircik

MD, FAAD


John Koo

MD


Please join us on Tue, Aug 10th, 2021 7:00 PM - 8:30 PM EDT for our next important webinar


July 13th 2021

Cleanse Like A Derm Global Press Event 2021


Please join us on Tue, July 13th, 2021 8:00 PM - 9:30 PM EDT for our next important webinar

About The past year has upended nearly every aspect of peoples’ lives, and skincare has been no exception. According to survey results from CeraVe, conducted online by IPSOS across 23 countries and over 10,100 respondents, 64 percent of people globally say that their cleansing routines have changed during the past 12 months.

In the context of this “new normal” of hygiene, access to trustworthy dermatological information is more important than ever. However, during this same time period, only 11 percent of individuals received information on cleansing directly from a dermatologist, with most respondents relying on family and friends, and social media to fuel their facial cleansing knowledge and routine choices.

To address this knowledge gap, CeraVe is partnering with leading dermatologists for our annual “Cleanse Like a Dermatologist” Press Event to share authoritative and relevant expertise on facial cleansing.


July 6th 2021

Red Faces and Understanding the Evaluation and Management of Persistent Facial Erythema in Adults with Rosacea

Leon Kircik

MD, FAAD


Zoe Draelos

MD, FAAD


Please join us on Tue, July 6th, 2021 7:00 PM - 8:30 PM EDT for our next important webinar

Please join us for an interactive session where Leon Kircik, MD, FAAD will begin with a new treatment paradigm for rosacea with emphasis on red faces. Our second interactive session is with Zoe Draelos, MD, FAAD, she will examine the role of neurovascular dysregulation in Rosacea, reviews current guidelines for the diagnosis and classification of rosacea based on disease phenotype, and discusses newly released long term treatment data (52 weeks) on the treatment of persistent facial erythema in rosacea.


July 6th 2021

Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color

Heather Woolery-Lloyd

MD, FAAD


Director, Skin of Color Division

Dr Phillip Frost Department of

Dermatology and Cutaneous Surgery

University of Miami

Miller School of Medicine

Andrew F. Alexis

MD, MPH


Center for Diverse Skin Complexions

Weill Cornell Medicine

New York, NY

Please join us on Tue, July 6th, 2021 12:00 PM - 1:00 PM EDT for our next important webinar

Multiple studies have compared skin barrier properties between different racial/ethnic populations. In this webinar, Andrew Alexis, MD, MPH, FAAD and Heather Woolery-Lloyd, MD, FAAD will help clarify the existing published data and provide consensus statements on variations in skin barrier properties in skin of color.


June 29th 2021

Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color

Heather Woolery-Lloyd

MD, FAAD


Director, Skin of Color Division

Dr Phillip Frost Department of

Dermatology and Cutaneous Surgery

University of Miami

Miller School of Medicine

Andrew F. Alexis

MD, MPH


Center for Diverse Skin Complexions

Weill Cornell Medicine

New York, NY

Please join us on Tue, June 29, 2021 7:00 PM - 8:00 PM EDT for our next important webinar

Multiple studies have compared skin barrier properties between different racial/ethnic populations. In this webinar, Andrew Alexis, MD, MPH, FAAD and Heather Woolery-Lloyd, MD, FAAD will help clarify the existing published data and provide consensus statements on variations in skin barrier properties in skin of color.


June 14th 2021

Review of Pathophysiology of Psoriatic Disease & the Role of Targeting Cytokines in Treatment of Psoriatic Disease

Leon Kircik

MD, FAAD


International Dermatology Education Foundation

Clinical Professor of Dermatology

Icahn School of Medicine at Mount Sinai

Indiana University Medical Center

Medical Director

Physicians Skin Care, PLLC, Louisville, KY

DermResearch, PLLC, Louisville, KY

Skin Sciences, PLLC, Louisville, KY

April W. Armstrong

MD, MPH, FAAD


Professor of Dermatology

Associate Dean for Clinical Research

Vice Chair | Director

Clinical Trials and Outcomes Research

Director, Psoriasis Program

Department of Dermatology

Director, Psoriasis Program

Keck School of Medicine at USC

University of Southern California

George Han

MD, PhD, FAAD


Medical Director

Dermatology at the Mount Sinai Health System

Chief of Teledermatology

Department of Dermatology

Icahn School of Medicine at Mount Sinai, NY

Vice President

Dermatologic Society of Greater New York

Mark Lebwohl

MD, FAAD


Dean for Clinical Therapeutics

Chairman Emeritus

Department of Dermatology

Icahn School of Medicine at Mount Sinai, NY

Please join us on Mon, June 14, 2021 7:00 PM - 10:00 PM EDT for our next important webinar
ACCREDITED PROGRAM 3 AMA PRA Category 1 Credits™ & 3 ANCC Nursing Contact Hours

In this 3 hour session, Leon Kircik, MD, FAAD, Mark Lebwohl, MD, FAAD, April Armstrong, MD, MPH, and George Han, MD, PhD, will discuss a review of pathophysiology of psoriatic disease & the role of targeting cytokines in treatment of psoriatic disease.

Click Register link for more details


June 2021

Burning Out Acne: A Fireside Chat with Your Peers on Real World Acne Cases

Charles Lynde,

MD, FRCPC, DABD, FCDA


Chief Medical Director

The Lynde Institute for Dermatology

& Lynderm Research Inc

Associate Professor, University of Toronto

Department of Medicine

Jaggi Rao

MD, FRCPC


Clinical Professor

Division of Dermatology and Cutaneous Sciences

University of Alberta

Founder and Medical Director,

Telederm Canada Inc.

Board Certified Dermatologist

Please join us on Tue, June 15, 2021 7:00 PM - 8:00 PM EDT for our next important webinar

In this one hour educational session, join us as Drs Lynde and Rao conduct a fireside chat on real world acne cases.


May 18 2021

Implications for Treatment and Skin Care Recommendations for Acne Patients with Skin of Color

Heather Woolery-Lloyd

MD, FAAD


Director, Skin of Color Division

Dr Phillip Frost Department of

Dermatology and Cutaneous Surgery

University of Miami

Miller School of Medicine

Andrew F. Alexis

MD, MPH


Center for Diverse Skin Complexions

Weill Cornell Medicine

New York, NY

Please join us on Tue, May 18, 2021 7:00 PM - 8:00 PM EDT for our next important webinar provided by CeraVe and RBC Consultants.

In this webinar, Andrew Alexis, MD, MPH, FAAD and Heather Woolery-Lloyd, MD, FAAD will help you understand the differences in acne when comparing different ethnicities, discuss the challenges in treating acne and review therapeutic options and the role of moisturizers and cleansers in treating acne in the skin of color population. They will also Explore moisturizer & cleanser ingredients offering insights into the specific role of common key ingredients in moisturizer formulations


April 2021

LA FONDATION LA ROCHE-POSAY PRESENTS:GRANTS, RESEARCH & YOUR CAREER – TIPS ON HOW TO SUCCEED

Adam Friedman

MD, FAAD


John E. Harris

MD, PhD, FAAD


Dawn Z. Eichenfield,

MD, PhD, FAAD


Join us on Tuesday April 27, 2021 from 7pm to 8pm Est

Please join us for this interactive discussion where Dawn Z. Eichenfield, MD, PhD, FAAD, Adam Friedman, MD, FAAD, and John Harris, MD, PhD, FAAD speak about grants, research & your career – tips on how to succeed

All USA attendees who participate in the entire program will receive a gift bag of our products. Please allow 4-6 weeks for our third party vendor to fulfill shipment.


April 2021

Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare

Hilary Baldwin

MD, FAAD


Julie Harper

MD, FAAD


Join us on Tuesday April 13, 2021 from 7pm to 8pm Est

In this CeraVe SkinChat session, Hilary Baldwin, MD, FAAD and Julie Harper, MD, FAAD will discuss Rosacea, an inflammatory skin disease that leads to an impaired skin barrier function, commonly involves the face. Symptoms of rosacea can be bothersome and include pain, stinging, burning, itching, and facial flushing. This presentation explores skin barrier impairment in rosacea and reduced symptomatology when using over-the-counter (OTC) skincare products.



March 2021

Targeted Oral Antibiotic Treatment in Dermatology: The Path to Optimizing Stewardship

Dr. Leon Kircik

MD, FAAD


James Q Del Rosso

DO, FAAD, FAOCD


Join us on Tuesday March 30, 2021 from 7pm to 8pm Est

This webinar will provide an overview of oral antibiotic use in dermatology.Emphasis will be placed on considerations related to their optimal use, clinical implications of antibiotic resistance, and recommendations to reduce emergence of resistant organisms as best as possible. Relevant literature will be reviewed.


 


March 2021

La place des chirurgies dans le traitement de l’hidradénite suppurée

Dr. Hélène Veillette

MD, FRCPC


Pascal St-Germain

MD, MSc. FRCSC,


Lundi, 22 March, 2021 7:00 PM - 8:00 PM EST Rejoignez-nous pour un webinaire

Agir en temps opportun pour le diagnostic et la prise en chargemultidisciplinaire et collaborative de la HS

Optimiser les résultats en combinant traitement médical et chirurgie

Identifier les patients qui seraient de bons candidats pour une chirurgie en HSet choisir l'option chirurgicale appropriée



March 2021

Expert Evening on Pearls and What’s New in Adolescent Dermatology

Charles Lynde,

MD, FRCPC, DABD, FCDA


Lawrence Schachner,

MD, FAAD, FAAP


Tuesday, March 9th, 2021 7:00 PM - 8:00 PM EST Join us for these important discussions

In this one hour educational session, join us asProfessor Schachner and Professor Lynde conducta fireside chat on their new modalities and pearls intreating adolescent dermatology


 

March 2021

What’s new in UV research? Exploring the impact of sun exposure on skin barrier

Charbel Bouez, PhD

Advanced Research Americas L'Oréal USA


Marek Haftek, MD, PhD

Emeritus Research Director, CNRS UMR 5305


Thursday, March 11h, 2021 12:00 PM - 1:00 PM EST Join us for these important discussions

Join us for this webinar where Dr Marek Haftek, Research Director at CNRS UMR 5305​ in Lyon France and Dr Charbel Bouez will share new research demonstrating the impact of UV radiation on skin barrier integrity, and the role ceramide-containing skincare can play in helping protect against UV-induced skin barrier damage.


 

February 2021

IDEF Educational Series: HOW TO NAVIGATE THE CHANGING LANDSCAPE OFDERMATOLOGY AND INDUSTRY (GENERIC/BIOSIMILAR)RELATIONSHIPS POST PANDEMIC

Dr. Leon Kircik

MD, FAAD


Thomas Seck, MD

Senior Vice President


Uday Baldota

Chief Executive Officer


Greg Besase

Head Of Diversified Therapeutics




February 2021

IDEF Educational Series: Who is Afraid of Big Bad Biologics? & An IL-23 Inhibitor for the Treatment of Plaque Psoriasis

Dr. Leon Kircik

MD, FAAD


Jeffrey LaDuca

PhD, MD


Tue, Feb 9, 2021 7:00 PM - 8:00 PM EST Join us for these important discussions

In this installment of the IDEF Educational series, Leon Kircik, MD, FAAD will lead the discussion on Who is Afraid of Big Bad Biologics?

Following this, Jeffrey LaDuca, PhD, MD will discuss An IL-23 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis.



February 2021

Choosing the Right Partner: Complementing Prescription Acne Medication with Over-the-Counter Cleansers and Moisturizers

Dr. Ted Lain

MD, MBA, FAAD


Dr. Kanokvalai Kulthanan

MD


Dr. Leon Kircik

MD, FAAD


Thursday February 4th, 2021 from 7:00PM- 8:00PM EDT Join us for these important discussions

Acne is the most common dermatological disorder. An impaired barrier function in acne vulgaris has been reported, as well as decreased amounts of epidermal ceramides. Also, many of the systemic and topical medications prescribed for the treatment of acne exacerbate these skin barrier disruptions and can lead to irritation and dry skin conditions.

This discussion will explore the importance of maximizing adjunctive skincare, such as over-the-counter products for managing acne and avoiding adverse effects.



December 2020

THE ROLE OF SKIN CARE IN ONCOLOGY PATIENTS EDUCATIONAL SERIES

Dr. Maxwell Sauder

MD, FRCPC, DABD


Dr. Joël Claveau

MD, FRCPC


Monday December 14th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions

During this one hour webinar, we will explore to what extent Canadians are living with or surviving from cancer with an increasing number of anti-cancer treatment induced cutaneous side effects that can severely impact quality of life and ultimately treatment outcomes.

Our experts, Dr. Maxwell Sauder and Dr. Joël Claveau, will provide practical best practice strategies to mitigate skin toxicities that are associated with oncology treatments, in an effort to improve patient quality of life, patient compliance as well as reduce treatment reduction, interruption and/or discontinuation.



November 2020

Acne in the time of COVID

Dr. Charles Lynde,

MD, FRCPC, DABD, FCDA


Dr. Jerry K. L. Tan,

MD, FRCPC


 

Monday November 30th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions

In this one hour educational session we will explore how to handle acne patients in the midst of this pandemic. In particular, how to manage our general and moderate-to-severe acne patients during and after this COVID-19 era. The advantages of isotretinoin, particularly, will be covered in our discussions and guidance from both professional and patient societies will be introduced.


November 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

Leon Kircik

MD, FAAD


Michael Shane Chapman

MD, MBA


Brad Glick

DO, MPH, FAOCD


Andrew Sulich

MD


Adam Friedman

MD, FAAD


ife

Details :

Tuesday November 17th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions

Join us as Dr. Michael Shane Chapman, MD, MBA, Dr. Brad Glick, DO, MPH, FAOCD and Dr. Andrew Sulich, MD discuss Joint Care in Dermatology & Rheumatology: A Real-World Perspective on Managing Plaque Psoriasis and Psoriatic Arthritis.

Followed by an educational discussion by Dr. Adam Friedman, MD, FAAD on A Different Approach to Treating Primary Axillary Hyperhidrosis.


 

November 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

ife

Details :

Monday November 2nd, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions

Join us as Dr Craig L. Leonardi, MD, FAAD discusses CIMZIA® (certolizumab pegol): An Anti-TNF for Skin and Joint Relief in Biologic-Experienced Patients.

Followed by an educational discussion by Dr Adam Friedman, MD, FAAD on Managing Psoriasis During a Pandemic.


 

November 2020

Mieux Connaître l’Hidradénite Suppurée

Modératrice

Dre Isabelle Delorme

MD, FRCPC, Dermatologue


Conférencière

Dre Hélène Veillette

MD, FRCPC, Dermatologue


abb

Objectifs :

Mardi le 3 Novembre 2020 de 19h00 à 20h00

- Sensibiliser les participants aux divers aspects du tableau clinique de la H.S. afin de raccourcir le délai diagnostic

- Mieux connaître la réalité vécue par les personnes atteintes de la H.S. et l’incidence de la maladie sur leur qualité de vie

- Assurer le traitement approprié grâce à une prise en charge collaborative et orienter au besoin le patient vers un dermatologue


 

October 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

ife

Details :

Monday October 26th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions

What will aesthetic/cosmetic medical industry relationships look like after COVID-19?

In this live webinar, Michael H. Gold, MD, FAAD, and Leon Kircik, MD, FAAD will lead the discussion on how the post-COVID-19 era will impact the future of the aesthetic industry relationship. A panel of key aesthetic industry executives will discuss their perspective of the future of aesthetics and how the industry is changing to adapt to serve the needs of the aesthetic community.

A high level of interaction will be incorporated with several polling questions and an extensive Q&A period.


 


October 2020

A Patient’s Journey With Atopic Dermatitis

Adam Friedman

MD, FAAD


Professor and Interim Chair of Dermatology

Residency Program Director

Director of Transnational Research

Director of Supportive Oncodermatology Clinic

Department of Dermatology

George Washington School of Medicine and Health Sciences

Jason Lee-LLacer And Agnes Abedela, RN, MSN

MD


Jason Lee-LLacer is a Critical Care

Medicine Specialist in Lanham MD

Join us for a live webinar for a panel discussion between Adam Friedman, MD and his patient, Jason Lee-Llacer, MD and his wife Agnes Abedela, RN, as they discuss his struggle with severe atopic dermatitis. This includes the various drug and adjunctive therapies used to treat and manage his condition. This panel discussion will include Q&A. Jason Lee-Llacer, MD and Agnes Abedela, RN are ICU health care providers. His AD caused severe QOL concerns, including loss of sleep, which impacted his work and social life. Part of Dr. Lee-Llacer’s treatment included two weeks of balneotherapy at the Thermal Dermatology center in La Roche-Posay, France.


October 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

ife

Details :

Tuesday October 6th, 2020 from 7:00PM- 8:00PM EDT Join us for these important discussions

The first part of this webinar will address the pathogenesis of hyperhidrosis and its psychosocial impact on our patients as well as emerging treatment options.

The second part of the webinar will discuss the use of Ixekizumab for psoriasis and psoriatic arthritis patients with a focus on its new pediatric indication in psoriasis.


 


September 2020

Skin Barrier Integrity and Skin of Color: What you need to know!

Heather Woolery-Lloyd

MD, FAAD


Director, Skin of Color Division

Dr Phillip Frost Department of

Dermatology and Cutaneous Surgery

University of Miami

Miller School of Medicine

Andrew F. Alexis

MD, MPH


Director, Skin of Color Center

Chair, Department of Dermatology

Mount Sinai Morningside and

Mount Sinai West

Professor, Icahn School of Medicine

at Mount Sinai

Please join us for our next important webinar provided by CeraVe and RBC Consultants.

This presentation will cover what you need to know about the role of the skin barrier in the skin of color patient. Although conflicting data exists, several studies have confirmed key differences in the skin barrier when comparing different ethnicities. We will discuss both the clinical and cultural significance of moisturizers in skin of color patients. We will also decode moisturizer ingredients offering insights into the specific role of common key ingredients in moisturizer formulations.


September 2020

Newborn and Infant Skincare: Update on Sensitive Skin Care and Barrier function: What you need to know!

Lawrence Schachner

MD, FAAD, FAAP


Stiefel Professor

Chairman Emeritus Dermatology

Professor of Dermatology and Pediatrics

Director of Pediatric Dermatology

University of Miami School of Medicine

Peter Lechman

MD, MBA, FAAP


Associate Chief Medical Officer for Primary Care

Medical Director, Primary Care and Pediatrics

Northwestern Medical Group

Instructor of Clinical Pediatrics at

Northwestern University Feinberg School of Medicine

Attending Physician at the

Anne and Robert H. Lurie Children’s Hospital of Chicago


This presentation will provide what you need to know about the role of newborn and infant skincare in promoting important short-term and long-term health benefits to your patients. The skin of babies is still undergoing maturation during the first days, weeks, months and early years of life.

Appropriate skin care can help this maturation in barrier function and structure, decrease skin sensitivity and potentially halt the atopic march towards systemic allergic disease. We will discuss the barrier maturation and function of babies skin, simple but effective care, as well as potential transcutaneous toxicities to avoid.



August 2020

The Role of Ceramides in Skin Barrier Integrity: What You Need to Know!

Daniela P. Antelo

MD, MSC, PhD


Adjunct Professor of Dermatology

Universidade do Estado

Rio de Janeiro, Brazil

Chief of Cosmetic Dermatology

Sector of

Hospital Universitario Pedro Ernesto

Master Degree and PhD at

Dermatology

Federal University of Rio de Janeiro

Carmen Gloria Gonzalez

MD


Pediatric Dermatologist

Fellowship in Pediatric Dermatology

Feinberg School of Medicine.

Northwestern University

Member of American Academy of Dermatology

Society in Pediatric Dermatology and

European Society of Pediatric Dermatology

Associate Editor of Practical and

Conceptual Dermatology Journal


We wanted to thank everyone for attending our most recent educational webinar, The Role of Ceramides in Skin Barrier Integrity: What You Need to Know!

Dr. Daniela P. Antelo and Dr. Carmen Gloria Gonzalez both delivered excellent talks on skin barrier anatomy and function and effectiveness of Ceramide use in dermatology.



July 2020

A Forgotten Concept: pH and Skin Barrier

Leon Kircik

MD


Professeur clinique de dermatologie

École de médecine Icahn à Mount Sinai, NY

Directeur médical

Sciences de la peau, Louisville, KY

Charles W. Lynde

MD


Directeur médical

Le Lynde Institute for Dermatology &

Recherche Lynderm Inc.

professeur agrégé

Université de Toronto, Département de médecine

Details :

August 12th, 2020 at 8:00PM EDT

In this LIVE webinar, Leon Kircik, MD, FAAD and Charles Lynde, MD, FRCPC, will be reviewing the role of skin surface pH in skin barrier function as well as the challenges in balancing pH in atopic dermatitis and acne patients.

They will also be providing clinical insights into the role of skin pH in AD and acne patients as well as clinical data on the importance of moisturizers and cleansers in skin barrier function.


download (2)

Watch our Webinar with Dr. Charles W. Lynde and Dr. Leon Kircik

Click on the Youtube logo to subscribe to our channel for our upcoming Webinars.


July 2020

INTERNATIONAL DERMATOLOGY EDUCATION FOUNDATION EDUCATIONAL SERIES

ife

Details :

Thursday Jul 30th, 2020 from 8:00PM- 9:00PM EDT

- Amidst the use of personal protection equipment (PPE) during COVID 19 pandemic, we are discovering the indirect impact of the virus on our skin.

- During this session, Dr. Leon Kircik will discuss the relevant cutaneous findings and the disruption of barrier function caused with the extensive use of masks, hand sanitizers, and other PPE . We will emphasize the importance of barrier restoration with unique ceramide formulation skincare as well as the importance of maintaining natural skin pH.

- In addition, Dr. Linda Stein Gold will present on how to progress your topical patients to the next step with an oral treatment with data for moderate to severe scalp psoriasis.

-Dr Doris Day will review systemic and local effects of stress on the hair follicle and the benefits of proactive interventions.


 


July 2020

Comment naviguer dans le paysage changeant de la dermatologie et des relations de l'industrie après la pandémie

ife

Objectifs :

Mercredi le 29 Juillet, 2020 from 8:00PM- 9:00PM EDT

- Dans ce webinaire interactif en direct, le Dr Marc Bourcier partagera son point de vue sur la façon dont l’ère post COVIDE-19 aura un impact sur l’interaction de la communauté dermatologique avec l’industrie. Un groupe de dirigeants clés de l’industrie discutera de la façon dont l’industrie s’adapte à la situation pendant la pandémie de Covide-19 afin de répondre aux besoins de la communauté dermatologique au Québec. En outre, un leader d’opinion clé, le Dr Charles Lynde, partagera une perspective plus poussée du restant du Canada et le Dr Leon Kircik, partagera une perspective plus poussée du sud de la frontière. Un niveau élevé d’interactivité sera intégré à plusieurs questions de sondage et à une longue période de questions-réponses. Cette séance offrira a la communauté dermatologique et aux chefs de file de l’industrie l’occasion de mieux comprendre et d’explorer la façon de naviguer dans la « nouvelle normalité » pour les relations futures.

Altius Healthcare

Sybil Dahan

Présidente


Bausch Health

Richard Lajoie

President, Canada


Dermtek Pharma

Michel Lavoie

Président


Galderma Canada

Wendy Adams

Directeur général Canada



 


July 2020

For a Webinar discussing Antibiotics, Probiotics and Antibiotic Stewardship in the SARS-COV 2 ERA

Ellie Goldstein

MD


Stuart Johnson

MD


Ravina Kullar

PharmD


Lynne McFarland

PhD



The COVID 19 pandemic has locked down countries and stressed hospital systems worldwide. Patients who are admitted to the hospital, especially those with respiratory complications, are frequently placed on empirical antibiotics in part due to the fear of aerosolization of the virus, despite limited data showing low rates of bacterial and fungal infections. When patients get sicker, antibiotics are often empirically escalated, creating an inherent dilemma for the hospital’s Antimicrobial Stewardship program (ASP). The additional use of antibiotics, especially in ICU patients, can potentially lead to drug toxicities, allergies, prolonged hospital stays, increased bacterial resistance and associated complications such as C. difficile infection (CDI). CDI, with 428,000 cases per year with 5.2% attributable mortality, costs insurers approximately $5 billion dollars (US) in excess medical costs and is considered an urgent global threat by the WHO and CDC. Hospital ASP teams have begun to lower these rates with more restrictive antibiotic use protocols. The use of specific strains of probiotics has been shown to effectively reduce antibiotic-associated diarrhea and CDI in several randomized controlled trials (RCTs), but not all probiotic strains or mixtures are effective. An innovative strategy which involves administering specific probiotics to every inpatient who receives an antibiotic and continuing the probiotic for the duration of the antibiotic course or until discharge is proposed as an essential element of an effective CDI prevention bundle.

July 2020

How to navigate the changing landscape of dermatology and industry relationships post pandemic

Charles W. Lynde

MD


Medical Director, The Lynde Institute for

Dermatology& Lynderm Research Inc.

Associate Professor, University of Toronto,

Department of Medicine

Chair: Leon Kircik

MD


Clinical Professor of Dermatology

Icahn School of Medicine at Mount Sinai, NY

Medical Director, Skin Sciences, Louisville, KY

ife

Details

Thursday, July 23st, 2020 from 7:00PM- 8:30PM EDT

- In this live webinar, Charles W. Lynde, MD, and Leon Kircik, MD will lead the discussion on how the post-COVID-19 era will impact the future of the dermatology industry relationship. A panel of key pharmaceutical executives will discuss their perspective of the future of dermatology and how the industry is changing to adapt to serve the needs of the dermatology community. A high level of interaction will be incorporated with several polling questions and an extensive Q&A period.

This session will offer both dermatology health care professionals and industry leaders an opportunity to better understand and explore how to navigate the “new normal”.

Bausch Health

Richard Lajoie

President, Canada


Galderma Canada

Wendy Adams

General Manager


Novartis Pharmaceuticals

Andrea Marazzi

Country Pharma Organization Head


UCB Canada

Jerry Syrotuik

Scientific Head of Immunology



 

July 2020

How to navigate the changing landscape of dermatology and industry relationships post pandemic

ife

Details

Tuesday, July 21st, 2020 from 7:00PM- 8:30PM EDT

- In this live webinar, Leon Kircik, MD and Mark Lebwohl, MD will lead the discussion on how the post-COVID-19 era will impact the future of dermatology industry relationship. A panel of key pharmaceutical executives will discuss their perspective of the future of dermatology and how the industry is changing to adapt to serve the needs of the dermatology community. A high level of interaction will be incorporated with several polling questions and an extensive Q&A period. We will also have a guest ,Dr Charles Lynde from Canada who will give us Canadian viewpoint.

This session will offer both dermatology health care professionals and industry leaders an opportunity to better understand and explore how to navigate the “new normal” .

Arcutis Biotherapeutics

Frank Wantanabe

President and CEO


Bausch Health

Richard Lajoie

President, Canada


Brickell Biotech

Robert Brown

CEO


Cassiopea

Diana Harbort

CEO


Dermavant

Todd Zavodnick

CEO



Leo Pharma

Chris Posner

President and CEO


Lilly

Becki Morison

Immunology Leader USA


Novartis

Victor Bulto

President


Ortho Dermatologics

Bill Humphries

President


UCB

Rhonda Peebles

Head US Dermatology



 

July 2020

Face and Hands: Insights Into The Impact of COVID-19 on Skin Barrier Integrity

Dr. Charles W. Lynde

MD, FRCPC, DABD, FCDA


Dr. Leon Kircik

MD, FAAD


ife

Details

Wednesday, July 15th 2020 from 7:00PM- 8:00PM

- Amidst the use of personal protection equipment (PPE) during the COVID 19 pandemic, we are discovering the indirect impact of the virus on our skin.

- During this session, we will discuss the relevant cutaneous findings and the disruption of barrier function caused by the extensive use of masks, hand sanitizers, and other PPE. We will emphasize the importance of barrier restoration with unique ceramide formulation skincare as well as the importance of maintaining natural skin pH.

FREE GIFTS TO ALL ATTENDEES


download (2)

Watch our Webinar with Dr. Charles W. Lynde and Dr. Leon Kircik

Click on the Youtube logo to subscribe to our channel for our upcoming Webinars.


July 2020

Mieux Connaître l’Hidradénite Suppurée

Modératrice

Dre Isabelle Delorme

MD, FRCPC, Dermatologue


Conférencière

Dre Hélène Veillette

MD, FRCPC, Dermatologue


abb

Objectifs :

Lundi le 13 juillet 2020 de 19h00 à 20h00

- Sensibiliser les participants aux divers aspects du tableau clinique de la H.S. afin de raccourcir le délai diagnostic

- Mieux connaître la réalité vécue par les personnes atteintes de la H.S. et l’incidence de la maladie sur leur qualité de vie

- Assurer le traitement approprié grâce à une prise en charge collaborative et orienter au besoin le patient vers un dermatologue